Dylan H. de Vries

Dylan H. de Vries

Auto-generated profile, based on publicly available information

Dylan H. de Vries

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
UVUrmo Võsa
Urmo Võsa
ACAnnique Claringbould
Annique Claringbould
HWHarm-Jan Westra
Harm-Jan Westra
MBMarc Jan Bonder
Marc Jan Bonder
PDPatrick Deelen
Patrick Deelen
LFLude Franke
Lude Franke

2 April 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LSLifeLines Cohort Study
LifeLines Cohort Study
MWMonique G. P. van der Wijst
Monique G. P. van der Wijst
BCBIOS Consortium
BIOS Consortium
HBHarm Brugge
Harm Brugge
DVDylan H. de Vries
Dylan H. de Vries
LFLude Franke
Lude Franke
Genome-wide association studies have identified thousands of genetic variants that are associated with disease1. Most of these variants have small effect sizes, but their downstream expression effects, so-called expression quantitative trait loci (eQTLs), are often large2 and celltype-specific3,4,5. To identify these celltype-specific eQTLs using an unbiased approach, we used single-cell RNA sequencing to generate expression profiles of ~25,000 peripheral blood mononuclear cells from 45 donors. We identified previously reported cis-eQTLs, but also identified new celltype-specific cis-eQTLs. Finally, we generated personalized co-expression networks and identified genetic variants that significantly alter co-expression relationships (which we termed ‘co-expression QTLs’). Single-cell eQTL analysis thus allows for the identification of genetic variants that impact regulatory networks.

1 January 2018 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
VFVíctor Faundes
Víctor Faundes
WNWilliam Newman
William Newman
LBLaura Bernardini
Laura Bernardini
NCNatalie Canham
Natalie Canham
JCJill Clayton-Smith
Jill Clayton-Smith
MHMatthew E. . Hurles
Matthew E. . Hurles

7 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
RORoy Oelen
Roy Oelen
DVDylan H. de Vries
Dylan H. de Vries
HBHarm Brugge
Harm Brugge
MGM. Grace Gordon
M. Grace Gordon
MVMartijn Vochteloo
Martijn Vochteloo
MWMonique G. P. van der Wijst
Monique G. P. van der Wijst
The host’s gene expression and gene regulatory response to pathogen exposure can be influenced by a combination of the host’s genetic background, the type of and exposure time to pathogens. Here we provide a detailed dissection of this using single-cell RNA-sequencing of 1.3M peripheral blood mononuclear cells from 120 individuals, longitudinally exposed to three different pathogens. These analyses indicate that cell-type-specificity is a more prominent factor than pathogen-specificity regarding contexts that affect how genetics influences gene expression (i.e., eQTL) and co-expression (i.e., co-expression QTL). In monocytes, the strongest responder to pathogen stimulations, 71.4% of the genetic variants whose effect on gene expression is influenced by pathogen exposure (i.e., response QTL) also affect the co-expression between genes. This indicates widespread, context-specific changes in gene expression level and its regulation that are driven by genetics. Pathway analysis on theCLEC12Agene that exemplifies cell-type-, exposure-time- and genetic-background-dependent co-expression interactions, shows enrichment of the interferon (IFN) pathway specifically at 3-h post-exposure in monocytes. Similar genetic background-dependent association between IFN activity andCLEC12Aco-expression patterns is confirmed in systemic lupus erythematosus by in silico analysis, which implies thatCLEC12Amight be an IFN-regulated gene. Altogether, this study highlights the importance of context for gaining a better understanding of the mechanisms of gene regulation in health and disease.

19 December 2018 in Genome Medicine
Verified
Journal Article
Open access
PDF file
MWMonique G. P. van der Wijst
Monique G. P. van der Wijst
DVDylan H. de Vries
Dylan H. de Vries
HBHarm Brugge
Harm Brugge
HWHarm-Jan Westra
Harm-Jan Westra
LFLude Franke
Lude Franke
Only a small fraction of patients respond to the drug prescribed to treat their disease, which means that most are at risk of unnecessary exposure to side effects through ineffective drugs. This inter-individual variation in drug response is driven by differences in gene interactions caused by each patient’s genetic background, environmental exposures, and the proportions of specific cell types involved in disease. These gene interactions can now be captured by building gene regulatory networks, by taking advantage of RNA velocity (the time derivative of the gene expression state), the ability to study hundreds of thousands of cells simultaneously, and the falling price of single-cell sequencing. Here, we propose an integrative approach that leverages these recent advances in single-cell data with the sensitivity of bulk data to enable the reconstruction of personalized, cell-type- and context-specific gene regulatory networks. We expect this approach will allow the prioritization of key driver genes for specific diseases and will provide knowledge that opens new avenues towards improved personalized healthcare.

1 June 2019 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
AOAnne H. O’DOnnell-Luria
Anne H. O’DOnnell-Luria
LPLynn S. Pais
Lynn S. Pais
VFVíctor Faundes
Víctor Faundes
JWJordan C. Wood
Jordan C. Wood
ASAbigail Sveden
Abigail Sveden
LRLance H. Rodan
Lance H. Rodan